p 614.00 <%= Resources.Global.txtDown %>
Updated 18/05/2018
Change % -2.46% Stock price decreasing
Change -15.50 Stock price decreasing
Volume 1,057,823
High P 626.50
Low P 605.00
Open P 612.00
ISIN GB0001001592
Prev close P 629.50
# of shares 386.49M
Market cap 237,307M GBX

Market closed
Market is closed, opens at 08:00
Price development Latest 1 week 1 month 3 months 6 months 1 year
  614.00 -7.3% Stock price decreasing -7.5% Stock price decreasing -9.4% Stock price decreasing -20.4% Stock price decreasing -3.6% Stock price decreasing
Powered by TradingView

Company profile

BTG is a biotechnology company that develops products in specialty areas of medicine. The company's three operating segments are interventional medicine, specialty pharmaceuticals, and licensing. Its interventional medicine focuses on oncology, vascular treatments, and pulmonology. BTG's revenue is roughly split between these three segments, while its oncology operations lead the interventional segment. The company has been known to utilize acquisitions for investing in leading therapies and capabilities.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
21 May 2018 02:00:33
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180515.2 - EUROWEB5 - 2018-05-21 03:00:33 - 2018-05-21 02:00:33 - 1000 - Website: OKAY